Doctor Johannes Wikstrom
(Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Combination therapy with GalNAc-siRNA drugs targeting both PCSK9 and APOC3 resulted in enhanced lipid lowering in mice
Event: ESC Congress 2024
Topic: Drug therapy
Session: Lipids as cardiovascular risk factors and treatment options
Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats
Event: ESC Congress 2023
Topic: Angiotensin-Renin-Bradykinin System
Session: Clinical pharmacology
